A clinical team can produce a table quickly and still take days to answer a simple follow-up: which participants contributed, which rule selected them, and which version of the analysis plan governed the result? The delay arises between artifacts. Data, documents, programs, and review comments can each be well organized while their relationships remain difficult to recover.
Evidence continuity means preserving those relationships as work progresses. It gives a reviewer a practical path from a clinical question to a result and back to the assumptions that shaped it. It is an operating discipline, rather than a claim that placing files in one application automatically makes them reliable.
1. Treat the question as a durable object
Consider a hypothetical review of treatment discontinuations. A chart alone cannot distinguish discontinuation of study treatment from withdrawal of consent or the end of follow-up. Before generating it, record the population, event definition, observation period, and intended comparison. Keep the question attached to the output when it is shared.
ICH E9(R1) provides the framework for defining treatment effects. Our practical recommendation is to carry that intent into everyday review: a small question record should identify the relevant endpoint and explain whether the analysis is exploratory or prespecified. A reviewer should not have to infer its status from presentation quality.
2. Preserve the execution context
A useful result record contains the data snapshot identifier, input datasets, program version, parameters, environment, execution time, and review status. These are proposed working conventions, not a universal checklist imposed by one standard. They allow a colleague to distinguish a rerun from a new analysis and to identify what changed.
The CDISC Analysis Results Standard is a relevant foundation for structured results metadata. Teams can begin modestly: select a recurring display, agree on its identifying information, and test whether another programmer can reconstruct it without an explanatory meeting.
3. Make the return journey possible
Forward traceability shows how data produced an output. Review also needs the reverse direction. A surprising estimate should lead to contributing records, derivation rules, and the pertinent study document. The return journey often reveals whether the issue is clinical, statistical, or operational.
Astraea’s connected workspace brings study exploration, documents, and inspectable analysis into the same review context. The wider goal is to reduce the distance between a question and its evidence. That goal does not replace formal validation, statistical approval, or sponsor oversight.
4. Measure the cost of reconstruction
Rather than counting dashboards, examine three recent review questions. How long did it take to identify the correct data cut? Could the team locate the governing rule? Did the second reviewer reproduce the result? Record the obstacles and fix the most repeated dependency first.
The strongest sign of progress is a more focused review conversation. When evidence is recoverable, teams can spend more time discussing what a result means and less time reconstructing how it came into existence.
